Equities

Sareum Holdings PLC

SAR:LSE

Sareum Holdings PLC

Actions
Health CarePharmaceuticals & Biotechnology
  • Price (GBX)0.65
  • Today's Change0.00 / 0.00%
  • Shares traded3.73m
  • 1 Year change-23.53%
  • Beta0.8151
Data delayed at least 20 minutes, as of Dec 14 2018 16:35 GMT.
More ▼

Key statistics

On Friday, Sareum Holdings PLC (SAR:LSE) closed at 0.65, 14.44% above the 52 week low of 0.568 set on Dec 13, 2018.
52-week range
Today
0.568Dec 13 20181.05Feb 27 2018
Open0.600
High0.65
Low0.65
Bid--
Offer--
Previous close0.65
Average volume3.69m
Shares outstanding2.88bn
Free float2.73bn
P/E (TTM)--
Market cap18.69m GBP
EPS (TTM)-0.0005
GBP
Data delayed at least 20 minutes, as of Dec 14 2018 16:35 GMT.
More ▼

Board of Directors

1/3

Stephen Parker, Non-Executive Chairman

2/3

Tim Mitchell, Founder and CEO

3/3

John Reader, Founder and CSO

Contact

Head Office
Sareum Limited.
Unit 2A, Langford Arch
London Road, Pampisford
Cambridge
CB22 3FX
United Kingdom

tel: +44 (0) 1223 497700
fax: +44 (0) 1223 497701
email.png 

Registered in England No. 4863659
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.